Top compounds associated with response to NLRP3


Feature Type Standardized
Nominal ANOVA
mRNA Sorafenib GDSC1000 pan-cancer AAC 0.33 2e-09
mRNA RDEA119 GDSC1000 pan-cancer AAC 0.19 2e-09
mRNA Bexarotene GDSC1000 pan-cancer AAC 0.21 8e-09
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 1e-08
mRNA CI-1040 GDSC1000 pan-cancer AAC 0.18 3e-08
mRNA PD-0325901 GDSC1000 pan-cancer AAC 0.18 3e-08
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 5e-08
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 8e-08
mRNA Midostaurin GDSC1000 pan-cancer AAC 0.19 9e-08
mRNA BX-795 GDSC1000 pan-cancer AAC 0.19 1e-07
Download CSV